
Your support will fund urgent research to...

![]() |
PREVENT |
Prevent breast cancer through precision prevention.
![]() |
DETECT |
Detect breast cancer as early as possible and before it progresses.
![]() |
STOP |
Stop the progression and recurrence of breast cancer.
![]() |
TREAT |
More effectively treat hard-to-treat and metastatic breast cancers.

The funds you raise are vital. The more you raise, the closer we get to our vision of Zero Deaths from breast cancer.


Could support researchers to develop new therapies for hard-to-treat breast cancers.

Could support researchers to uncover more targeted and personalised treatments with fewer side-effects.

Could support researchers to develop a simple blood test to predict, detect and monitor the return and spread of breast cancer.
WHERE YOUR MONEY GOES
When you support the National Breast Cancer Foundation (NBCF), you’re supporting world-class research of outstanding scientific quality and potential to contribute towards NBCF’s vision of Zero Deaths from breast cancer.
These projects are funded in meritorious order via NBCF’s independent and rigorous review system. NBCF funds ground-breaking research focussed on better understanding how to prevent and detect breast cancer early, how to stop the progression and recurrence of breast cancer and how to effectively treat hard-to-treat and metastatic breast cancers – research that ultimately save lives.
PROFESSOR CHRISTOBEL SAUNDERS AO – UNIVERSITY OF MELBOURNE
Project name: STRENGTHENING AUSTRALIA’S LEADING RESOURCE FOR UNDERSTANDING INHERITED BREAST CANCER RISK
The Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab) is Australia’s national resource for studying inherited (familial) breast cancer. Professor Christobel Saunders and her team at the University of Melbourne will strengthen and expand this resource to help researchers identify more genetic and lifestyle risks, improve preventive and early detection methods, and develop personalised treatments for high-risk people affected by breast cancer.
LEARN MORE
PROFESSOR IAN CAMPBELL
Project name: Identifying genetic risk factors and new treatments for young breast cancer patients
Early-onset breast cancers, defined as breast cancer occurring in women less than 45 years old, account for about 7% of all new female breast cancer and approximately 15% of breast cancer deaths. Among early-onset breast cancers are a substantial proportion where the breast cancer diagnosis occurs during or within one year after pregnancy, called pregnancy associated breast cancer. Prof Ian Campbell and colleagues will use the latest whole genome sequencing technologies to analyse a cohort of early-onset and pregnancy associated breast cancers. This information will be integrated with patients’ clinical data to discover new genes that contribute to an increased risk of breast cancer. This information will be valuable for improving risk management and uncovering potential new therapeutic targets.
LEARN MORE




